España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Context Therapeutics
CNTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.15
0.17
17.35%
At close: -
$1.14
-0.01
-0.87%
After Hours: 3:05 PM EDT
Get Report
Comment
Context Therapeutics (CNTX) Forecast
News
Earnings
Context Therapeutics (CNTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Context Therapeutics (NASDAQ:CNTX) Stock
Context Therapeutics Stock (NASDAQ: CNTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 02, 2024
Context Therapeutics Enters $75M At-The-Marke...
Benzinga Newsdesk
Monday, November 25, 2024
D. Boral Capital Initiates Coverage On Contex...
Benzinga Newsdesk
Wednesday, November 06, 2024
Context Therapeutics Q3 EPS $(0.22) Misses $(...
Benzinga Newsdesk
Tuesday, October 22, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, September 23, 2024
HC Wainwright & Co. Reiterates Buy on Context...
Benzinga Newsdesk
Context Therapeutics Secures Global Rights to...
Benzinga Newsdesk
Monday, September 16, 2024
HC Wainwright & Co. Reiterates Buy on Context...
Benzinga Newsdesk
Wednesday, August 07, 2024
Context Therapeutics Q2 2024 Adj EPS $(0.04) ...
Benzinga Newsdesk
Wednesday, July 10, 2024
HC Wainwright & Co. Reiterates Buy on Context...
Benzinga Newsdesk
Context Therapeutics Acquires Phase 1-Ready T...
Benzinga Newsdesk
Wednesday, June 05, 2024
Context Therapeutics 13G Filing Shows Great P...
Benzinga Newsdesk
Thursday, May 16, 2024
Piper Sandler Initiates Coverage On Context T...
Benzinga Newsdesk
Monday, May 13, 2024
Context Therapeutics 13G Filing Shows Avidit...
Benzinga Newsdesk
Friday, May 10, 2024
Deep Track Capital Reports Passive Stake Of 9...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Maintains Buy on Context ...
Benzinga Newsdesk
Maxim Group Maintains Buy on Context Therapeu...
Benzinga Newsdesk
Wednesday, May 08, 2024
Context Therapeutics Q1 EPS $(0.23) Beats $(0...
Benzinga Newsdesk
Tuesday, May 07, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Thursday, May 02, 2024
Context Therapeutics Announces $100M Private ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Context Therapeutics shares are trading highe...
Benzinga Newsdesk
Context Therapeutics Announces FDA Clearance ...
Benzinga Newsdesk
Monday, April 01, 2024
Context Therapeutics Submitted An FDA Investi...
Benzinga Newsdesk
Thursday, March 21, 2024
HC Wainwright & Co. Maintains Buy on Context ...
Benzinga Newsdesk
Context Therapeutics Reported FY23 EPS Loss o...
Benzinga Newsdesk
Friday, January 12, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Friday, December 15, 2023
Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Friday, December 08, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, November 09, 2023
Context Therapeutics Q3 EPS $(0.37) Down From...
Benzinga Newsdesk
Wednesday, November 01, 2023
Context Therapeutics shares are trading highe...
Benzinga Newsdesk
HC Wainwright & Co. Upgrades Context Therapeu...
Benzinga Newsdesk
Tuesday, October 31, 2023
Context Therapeutics Announces Preclinical Da...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, October 02, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Wednesday, September 27, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Monday, September 11, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 11, 2023
Benzinga Insights
Maxim Group Initiates Coverage On Context The...
Benzinga Newsdesk
Wednesday, August 09, 2023
Context Therapeutics Q2 EPS $(0.31) Down From...
Benzinga Newsdesk
Friday, August 04, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, July 19, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Thursday, June 08, 2023
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
Context Therapeutics
-
Sponsored
Tuesday, June 06, 2023
HC Wainwright & Co. Reiterates Neutral on Con...
Benzinga Newsdesk
Monday, June 05, 2023
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, June 01, 2023
Director at Context Therapeutics Acquires Company Stock Options Worth 50,000 Shares
Benzinga Insights
Director at Context Therapeutics Acquires Company Stock Options Worth 25,000 Shares
Benzinga Insights
Tuesday, May 16, 2023
ASCO 2023 Spotlight: Claudin 6 Anticipated To Shine
Context Therapeutics
-
Sponsored
Wednesday, May 10, 2023
Context Therapeutics Q1 EPS $(0.40) Down From $(0.22) YoY
Michael Horton
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch